Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Belgium's Solvay hikes 2022 profit forecast after first-quarter beat

Published 04/05/2022, 06:04
Updated 04/05/2022, 06:17
© Reuters. FILE PHOTO: The logo of Belgian chemical group Solvay is seen at its headquarters in Brussels, Belgium, July 29, 2015. REUTERS/Francois Lenoir
FTNMX552010
-
SLVYY
-

(Reuters) - Solvay (EBR:SOLB) SA on Wednesday raised its full-year core profit forecast after the Belgian chemicals group reported higher-than-expected first-quarter earnings, helped by price increases and volume growth.

The group, which makes lithium derivatives for batteries, now expects its full-year underlying earnings before interest, tax, depreciation and amortization (EBITDA) to grow by mid- to high-single digits, after it had previously forecast mid-single digit percentage growth.

"The critical and differentiated solutions that we provide to our customers enabled us to increase prices and more than compensate for the sharp cost increases in raw materials and energy," Chief Executive Officer Ilham Kadri said in a statement.

Solvay, which in March suspended its businesses and investments in Russia, said revenue from Russian activities represented less than 1% of the group's sales last year, and that the suspension had little impact.

"We have certainly much more than compensated for that through the growth in our businesses," Chief Financial Officer Karim Hajjar told Reuters.

Asked whether the company was planning to sell all or part of its Russian businesses, Kadri said no decision had been made on that front.

Solvay, which estimates between 5% and 10% of its gas may originate indirectly from Russia, said it was looking at other options, such as switching to alternative fuels.

"We are negotiating gas containment plans with industrial partners. We are going ahead with some key projects like LNG (liquid natural gas) pipeline contracting," Kadri said in a phone interview.

Solvay announced in March that it would separate into two independent public companies in 2023, one focused on chemicals and the other on specialty materials and solutions.

"For now, the timeline is confirmed and we are making progress since the announcements we did," the CEO said, adding that the reaction from investors has been "very positive".

Solvay, whose products range from base chemicals such as soda ash to speciality polymers, reported first-quarter EBITDA up 22.1% from a year earlier to 712 million euros ($749.24 million), above a company-provided consensus of 605 million euros.

© Reuters. FILE PHOTO: The logo of Belgian chemical group Solvay is seen at its headquarters in Brussels, Belgium, July 29, 2015. REUTERS/Francois Lenoir

Net sales in the January to March quarter were up 28.8% at 3.06 billion euros, beating a company-provided consensus of 2.76 billion euros.

($1 = 0.9503 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.